75 related articles for article (PubMed ID: 21544424)
1. Human lung carcinoma cells engineered to release IL2, IL7, GM-CSF and TNF alpha.
Guarini A; Riera L; Reato G; Carbone A; Cignetti A; Tos A; Lanfrancone L; Melani C; Paul R; Forni G; Foa R
Int J Oncol; 1996 Apr; 8(4):765-72. PubMed ID: 21544424
[TBL] [Abstract][Full Text] [Related]
2. Transfer of the interleukin-2 gene into human cancer cells induces specific antitumor recognition and restores the expression of CD3/T-cell receptor associated signal transduction molecules.
Guarini A; Riera L; Cignetti A; Montacchini L; Massaia M; Foa R
Blood; 1997 Jan; 89(1):212-8. PubMed ID: 8978294
[TBL] [Abstract][Full Text] [Related]
3. Transduction of the IL2 gene into human acute leukemia cells: induction of tumor rejection without modifying cell proliferation and IL2 receptor expression.
Cignetti A; Guarini A; Carbone A; Forni M; Cronin K; Forni G; Gansbacher B; Foa R
J Natl Cancer Inst; 1994 May; 86(10):785-91. PubMed ID: 8169977
[TBL] [Abstract][Full Text] [Related]
4. Role of neutrophils and lymphocytes in inhibition of a mouse mammary adenocarcinoma engineered to release IL-2, IL-4, IL-7, IL-10, IFN-alpha, IFN-gamma, and TNF-alpha.
Musiani P; Allione A; Modica A; Lollini PL; Giovarelli M; Cavallo F; Belardelli F; Forni G; Modesti A
Lab Invest; 1996 Jan; 74(1):146-57. PubMed ID: 8569177
[TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo characteristics of human squamous cell carcinoma of the head and neck cells engineered to secrete interleukin-2.
Nagashima S; Reichert TE; Kashii Y; Suminami Y; Chikamatsu K; Whiteside TL
Cancer Gene Ther; 1997; 4(6):366-76. PubMed ID: 9408607
[TBL] [Abstract][Full Text] [Related]
6. GM-CSF-transduced B16 melanoma cells are highly susceptible to lysis by normal murine macrophages and poorly tumorigenic in immune-compromised mice.
Kumar R; Yoneda J; Fidler IJ; Dong Z
J Leukoc Biol; 1999 Jan; 65(1):102-8. PubMed ID: 9886252
[TBL] [Abstract][Full Text] [Related]
7. IL-4 and TNF-alpha-mediated proliferation of the human megakaryocytic line M-O7E is regulated by induced autocrine production of GM-CSF.
Wadhwa M; Dilger P; Meager A; Walker B; Gaines-Das R; Thorpe R
Cytokine; 1996 Dec; 8(12):900-9. PubMed ID: 9050748
[TBL] [Abstract][Full Text] [Related]
8. Characteristics of ovarian cancer cells transduced by the bicistronic retroviral vector containing GM-CSF and HSV-TK genes.
Guan J; Ma L; Wei L
Chin Med J (Engl); 2001 Feb; 114(2):147-51. PubMed ID: 11780195
[TBL] [Abstract][Full Text] [Related]
9. IL-17 and IL-17F modulate GM-CSF production by lung microvascular endothelial cells stimulated with IL-1beta and/or TNF-alpha.
Numasaki M; Tomioka Y; Takahashi H; Sasaki H
Immunol Lett; 2004 Sep; 95(2):175-84. PubMed ID: 15388258
[TBL] [Abstract][Full Text] [Related]
10. Regulation of interleukin-1 and tumor necrosis factor-alpha induced granulocyte-macrophage colony-stimulating factor gene expression: potential involvement of arachidonic acid metabolism.
Rizzo MT; Boswell HS
Exp Hematol; 1994 Jan; 22(1):87-94. PubMed ID: 8282065
[TBL] [Abstract][Full Text] [Related]
11. Granulocyte-macrophage colony-stimulating factor expression is regulated at transcriptional and posttranscriptional levels in a murine bone marrow stromal cell line.
Derigs HG; Reifel-Miller A; Kaushansky K; Hromas RA; Boswell HS
Exp Hematol; 1994 Aug; 22(9):924-32. PubMed ID: 8062890
[TBL] [Abstract][Full Text] [Related]
12. In vitro modulation of tumor progression-associated properties of hormone refractory prostate carcinoma cell lines by cytokines.
Sokoloff MH; Tso CL; Kaboo R; Taneja S; Pang S; deKernion JB; Belldegrun AS
Cancer; 1996 May; 77(9):1862-72. PubMed ID: 8646686
[TBL] [Abstract][Full Text] [Related]
13. Combination of Fasl and GM-CSF confers synergistic antitumor immunity in an in vivo model of the murine Lewis lung carcinoma.
Ho MY; Sun GH; Leu SJ; Ka SM; Tang SJ; Sun KH
Int J Cancer; 2008 Jul; 123(1):123-33. PubMed ID: 18386791
[TBL] [Abstract][Full Text] [Related]
14. CREB regulates TNF-α-induced GM-CSF secretion via p38 MAPK in human lung fibroblasts.
Koga Y; Hisada T; Ishizuka T; Utsugi M; Ono A; Yatomi M; Kamide Y; Aoki-Saito H; Tsurumaki H; Dobashi K; Yamada M
Allergol Int; 2016 Oct; 65(4):406-413. PubMed ID: 27118435
[TBL] [Abstract][Full Text] [Related]
15. Costimulation of cutaneous T-cell lymphoma cells by interleukin-7 and interleukin-2: potential autocrine or paracrine effectors in the Sézary syndrome.
Foss FM; Koc Y; Stetler-Stevenson MA; Nguyen DT; O'Brien MC; Turner R; Sausville EA
J Clin Oncol; 1994 Feb; 12(2):326-35. PubMed ID: 8113839
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of established pancreatic cancers following specific active immunotherapy with interleukin-2 gene-transduced tumor cells.
Clary BM; Coveney EC; Philip R; Blazer DG; Morse M; Gilboa E; Lyerly HK
Cancer Gene Ther; 1997; 4(2):97-104. PubMed ID: 9080118
[TBL] [Abstract][Full Text] [Related]
17. Regression of established mouse leukemia by GM-CSF-transduced tumor vaccine: implications for cytotoxic T lymphocyte responses and tumor burdens.
Hsieh CL; Pang VF; Chen DS; Hwang LH
Hum Gene Ther; 1997 Nov; 8(16):1843-54. PubMed ID: 9382951
[TBL] [Abstract][Full Text] [Related]
18. Vaccination for experimental gliomas using GM-CSF-transduced glioma cells.
Herrlinger U; Kramm CM; Johnston KM; Louis DN; Finkelstein D; Reznikoff G; Dranoff G; Breakefield XO; Yu JS
Cancer Gene Ther; 1997; 4(6):345-52. PubMed ID: 9408604
[TBL] [Abstract][Full Text] [Related]
19. Fusion cytokine IL-2-GMCSF enhances anticancer immune responses through promoting cell-cell interactions.
Wen Q; Xiong W; He J; Zhang S; Du X; Liu S; Wang J; Zhou M; Ma L
J Transl Med; 2016 Feb; 14():41. PubMed ID: 26850448
[TBL] [Abstract][Full Text] [Related]
20. Different tumours, transduced with different cytokine genes as G-CSF and IL-2, show inhibition of tumour take through neutrophil activation but differ in T cell functions.
Stoppacciaro A; Forni G; Colombo MP
Folia Biol (Praha); 1994; 40(1-2):89-99. PubMed ID: 7525363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]